• LAST PRICE
    42.1300
  • TODAY'S CHANGE (%)
    Trending Up0.4400 (1.0554%)
  • Bid / Lots
    42.1000/ 7
  • Ask / Lots
    42.1600/ 9
  • Open / Previous Close
    41.5800 / 41.6900
  • Day Range
    Low 41.2900
    High 42.4400
  • 52 Week Range
    Low 27.9850
    High 50.9900
  • Volume
    277,716
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 41.69
TimeVolumeXENE
09:32 ET66441.58
09:37 ET10041.505
09:46 ET299841.69
09:48 ET70041.705
09:53 ET10041.705
10:00 ET100041.7
10:06 ET348941.895
10:08 ET30041.895
10:09 ET10041.895
10:11 ET40041.895
10:13 ET20041.895
10:15 ET20041.96
10:20 ET10041.96
10:26 ET130042.023
10:27 ET10042.16
10:29 ET30042.02
10:31 ET163041.85
10:33 ET120041.97
10:36 ET340041.96
10:38 ET20041.96
10:40 ET10042.01
10:42 ET119541.935
10:45 ET30042.01
10:47 ET52341.9152
10:49 ET10041.97
10:58 ET15042.015
11:00 ET10042
11:03 ET20042.015
11:05 ET10041.93
11:07 ET65041.965
11:12 ET150042.09
11:14 ET20042.08
11:18 ET3472042.04
11:20 ET110042.04
11:21 ET30042.04
11:32 ET10041.99
11:34 ET90042.04
11:36 ET20042
11:38 ET20042.03
11:39 ET30042
11:41 ET30042.01
11:43 ET20042.01
11:45 ET872341.99
11:48 ET106341.97
11:50 ET143742.025
11:52 ET35042
11:54 ET20041.985
11:56 ET20041.985
11:57 ET50041.955
12:03 ET10041.85
12:06 ET100041.99
12:08 ET40041.92
12:10 ET70041.99
12:12 ET1532441.95
12:14 ET10042
12:19 ET211142.055
12:21 ET30442.12
12:24 ET35042.16
12:28 ET10042.175
12:30 ET10042.175
12:32 ET100842.285
12:33 ET20042.285
12:39 ET30042.3
12:44 ET60042.36
12:48 ET285842.151
12:50 ET146842.17
12:53 ET279442.405
12:57 ET20042.405
01:04 ET30042.36
01:09 ET20042.33
01:13 ET10042.35
01:15 ET20042.385
01:18 ET100042.33
01:20 ET20042.32
01:22 ET10042.275
01:26 ET43442.165
01:27 ET20042.155
01:29 ET143642.2
01:31 ET70042.19
01:36 ET30042.28
01:42 ET20042.23
01:44 ET42142.28
01:45 ET382242.25
01:47 ET10042.23
01:49 ET60042.215
01:54 ET17242.27
01:56 ET10042.19
01:58 ET192542.28
02:02 ET10042.285
02:05 ET30042.265
02:07 ET50042.27
02:09 ET40042.27
02:12 ET10042.15
02:16 ET10042.19
02:18 ET155842.15
02:20 ET80042.13
02:21 ET40042.09
02:23 ET215542.11
02:25 ET60042.11
02:27 ET40042.11
02:30 ET102042.03
02:32 ET185142.05
02:34 ET133842.08
02:36 ET143642.1
02:38 ET40042.13
02:39 ET176942.17
02:41 ET3165042.09
02:43 ET150042.035
02:45 ET40841.935
02:48 ET164341.98
02:50 ET69942
02:52 ET30042
02:54 ET31341.985
02:56 ET236442.11
02:57 ET218942.19
02:59 ET70042.14
03:01 ET40042.18
03:03 ET229642.17
03:06 ET278442.135
03:08 ET80042.2
03:10 ET130042.25
03:12 ET90042.27
03:14 ET166642.27
03:15 ET275042.29
03:17 ET60042.27
03:19 ET10042.28
03:21 ET184642.33
03:24 ET120042.32
03:26 ET140042.36
03:28 ET30042.39
03:30 ET76442.395
03:32 ET100042.32
03:33 ET185842.27
03:35 ET190042.2
03:37 ET219942.13
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXENE
Xenon Pharmaceuticals Inc
3.2B
-15.4x
---
United StatesAPGE
Apogee Therapeutics Inc
3.2B
-25.2x
---
United StatesEWTX
Edgewise Therapeutics Inc
3.2B
-22.5x
---
United StatesVSBC
Vitaspring Biomedical Co. Ltd
3.1B
3,311.3x
---
United StatesMLTX
MoonLake Immunotherapeutics
3.0B
-51.9x
---
United StatesIOVA
Iovance Biotherapeutics Inc
3.4B
-6.8x
---
As of 2024-11-04

Company Information

Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the Company's lead Kv7 channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. Azetukalner is being developed for the treatment of epilepsy, including focal onset seizures (FOS) and primary generalized tonic-clonic seizures (PGTCS) as well as major depressive disorder (MDD). The Company is evaluating multiple therapeutic candidates targeting Kv7, Nav1.7, and Nav1.1 across various indications. It has an ongoing collaboration with Neurocrine Biosciences, Inc. to develop treatments for epilepsy.

Contact Information

Headquarters
3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
Phone
604-484-3300
Fax
604-484-3450

Executives

President, Chief Executive Officer, Director
Ian Mortimer
Chief Financial Officer
Sherry Aulin
Executive Vice President - Drug Discovery
James Empfield
Executive Vice President - Strategy and Innovation
Robin Sherrington
Chief Medical Officer
Christopher Kenney

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2B
Revenue (TTM)
$0.00
Shares Outstanding
75.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.21
EPS
$-2.74
Book Value
$12.31
P/E Ratio
-15.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.